Aretaeus Pharmaceuticals Pvt Ltd

VILTUS 50 Tablet 10's

MRP ₹80.00 (Inclusive of all taxes)
Deliver to

Netmeds First Membership

Starting at just ₹[] for 3 months.
View Plans

Introduction About VILTUS 50 TABLET

VILTUS 50 TABLET is used in adults to manage type 2 diabetes which helps to control the blood sugar levels when diet and exercise becomes insufficient to control the disease. It contains Vildagliptin which belongs to group of medicines called Oral Anti-diabetics.

Take VILTUS 50 TABLET as advised by your physician. Do not crush or chew VILTUS 50 TABLET. Swallow the medicine with a glass of water.

Along management with VILTUS 50 TABLET, your doctor might advise you to follow the diet and/or exercise which is beneficial. Avoid consumption of alcohol because it might lead to low blood glucose levels. Before taking VILTUS 50 TABLET, inform your doctor if you are on dialysis or have diabetic ketoacidosis (serious complication of diabetes), pancreatic disease, heart failure and liver or kidney disease.

VILTUS 50 TABLET is not recommended for use in pregnant and breast-feeding women, which is also not recommended for use in children and adolescents (aged below 18 years). It should be used with caution in elderly patients (aged 65 years and above).

The side effects of taking VILTUS 50 TABLET are dizziness, headache, joint pain and constipation.

Uses Of VILTUS 50 TABLET

  • Manage type 2 diabetes mellitus

How VILTUS 50 TABLET Works

VILTUS 50 TABLET controls blood glucose level by acting on the pancreas to produce more insulin and less glucagon which leads to low production of blood sugar levels resulting in controlled blood glucose levels.

How to use VILTUS 50 TABLET

  • Take VILTUS 50 TABLET as advised by your physician.
  • Do not crush or chew VILTUS 50 TABLET.
  • Swallow the medicine with a glass of water.
  • Your doctor will decide the correct dose and duration for you depending upon your age, body weight and disease condition.

Side Effects Of VILTUS 50 TABLET

Common Side Effects of VILTUS 50 TABLET:

  • Dizziness
  • Headache
  • Blurred vision
  • Constipation
  • Nausea, vomiting
  • Diarrhea
  • rashes

Stop taking VILTUS 50 TABLET and contact your doctor immediately if you experience any of the following side effects:

  • Signs of liver disease (hepatitis) such as loss of appetite or dark-colored urine, yellow skin and eyes, nausea
  • Signs of inflammation of the pancreas such as severe and persistent pain in the abdomen (stomach area), nausea and vomiting

Warning & Precautions

Pregnancy

Contraindicated

VILTUS 50 TABLET is not recommended for use in pregnant women.

Breastfeeding

Contraindicated

VILTUS 50 TABLET is not recommended for use in breastfeeding women or women who plan to breast-feed.

Driving and Using Machines

Use with Caution

Do not drive or operate any machines if you feel dizziness after taking VILTUS 50 TABLET.

Alcohol

Consult your doctor

Avoid consumption of alcohol while taking VILTUS 50 TABLET because it might lead to hypoglycemia (lowering of blood glucose levels).

Kidney

Use with Caution

VILTUS 50 TABLET should be used with caution in patients with moderate or severe kidney disease and in patients who are undergoing dialysis.

Liver

Use with Caution

VILTUS 50 TABLET should be used with caution in patients with liver disease.

Allergy

Contraindicated

Do not take VILTUS 50 TABLET if you are allergic to Vildagliptin or any other ingredients of this medicine.

Heart Disease

Use with Caution

VILTUS 50 TABLET should be used with caution in patients suffering from heart failure.

Use In Pediatrics

Contraindicated

VILTUS 50 TABLET is not recommended for use in children and adolescents up to 18 years of age.

Use In Geriatrics

Use with Caution

VILTUS 50 TABLET should be used with caution in elderly patients (aged 65 years and above).

Others

Before taking VILTUS 50 TABLET, inform your doctor if you:

  • Have type 1 diabetes (i.e. your body does not produce insulin)
  • Have a condition called diabetic ketoacidosis (serious complication of diabetes)
  • Have intolerance to certain sugars
  • Had or have a disease of the pancreas

Interactions

A. Drug-Drug interactions:

Before taking VILTUS 50 TABLET, inform your doctor if you are taking any of the following medicines:  

  • Oral antidiabetics (medicine used to manage type 2 diabetes) Ex. sulphonylureas such as gliclazide, glipizide
  • Digoxin (used to manage heart failure)   
  • Warfarin (used to manage blood clot)
  • Cardiac drugs (such as captopril, enalapril, fosinopril)
  • Simvastatin (used to reduce high cholesterol levels)  
  • Thiazides or other diuretics (medicines used to manage high blood pressure) Ex. chlorothiazide, chlorthalidone, hydrochlorothiazide
  • Corticosteroids (used to manage inflammation) Ex. prednisolone
  • Certain medicines affecting nervous system such as antidepressants Ex. clomipramine, amitriptyline
  • Thyroid medicines (used to lower thyroid levels) Ex. levothyroxine

Over dosage:

If you or anyone else accidentally takes too much of VILTUS 50 TABLET, consult your doctor immediately or visit the nearby hospital. Overdosage symptoms of VILTUS 50 TABLET are muscle pain, mild and transient paraesthesia (burning and prickling sensation in hands and legs), fever, oedema (swelling in arms and legs) and laboratory abnormalities such as transient increase in lipase levels, increases in creatine phosphokinase (CPK), aspartate aminotransferase (AST), C-reactive protein (CRP) and myoglobin levels.    

Synopsis

Drug :   Vildagliptin
Pharmacological Category :   Dipeptidyl peptidase-4 (DPP-4) inhibitors
Therapeutic Indication :   Type II diabetes mellitus          
Dosage Forms :   Tablet

More Information

 

 

FAQs About VILTUS 50 TABLET

Q: Can VILTUS 50 TABLET be used to manage diabetes mellitus?

A: Yes, VILTUS 50 TABLET lowers blood glucose levels and it is specifically used to manage type II diabetes mellitus which is a medical condition where the body does not make enough insulin or if the produced insulin that the body makes is not optimal leading to increased blood glucose levels in the body. Consult your doctor before taking VILTUS 50 TABLET.

Q: Can I take VILTUS 50 TABLET along with other hypoglycemic drugs like metformin or glimepiride?

A: Using VILTUS 50 TABLET along with other hypoglycemic drugs like metformin, glimepiride may drastically lower your blood glucose levels. So, be cautious and inform your doctor before taking any other anti-diabetic medicines.

Q: Does taking VILTUS 50 TABLET cause weight gain?

A: No, VILTUS 50 TABLET has no effect on weight gain. Moreover, these kinds of medicines delay gastric emptying and make you feel satiety (stomach fullness). These further decreases hunger. So, basically VILTUS 50 TABLET has no effect or it does not influence weight gain.

Q: How does VILTUS 50 TABLET work?

A: VILTUS 50 TABLET controls blood glucose level by acting on the pancreas to produce more insulin and less glucagon which leads to low production of blood sugar levels resulting in controlled blood glucose levels.

Q: Does VILTUS 50 TABLET cause dizziness?

A: Yes, VILTUS 50 TABLET may cause dizziness in some individuals. To manage this effect, lie down until dizziness is gone, then get up slowly. Move slowly and carefully, do not hurry. Get adequate rest. Drink plenty of water and other fluids. Avoid coffee, cigarettes, alcohol and drugs. Consult your doctor if the symptom gets worse.

Q: Can VILTUS 50 TABLET be used in children?

A: VILTUS 50 TABLET is not recommended for use in children and adolescents up to 18 years of age.

Q: What does VILTUS 50 TABLET contain?

A: It contains Vildagliptin which belongs to group of medicines called Oral Anti-diabetics.

References

1. KD. Tripathi. Insulin, Oral Hypoglycaemic Drugs and Glucagon. Essentials of medical pharmacology. Seventh edition. 2013. Page-275.

2. B Ahren, A Schweizer, S Dejager, E B Villhauer, B E Dunning, J E Foley. Mechanisms of action of the dipeptidyl peptidase-4 inhibitor vildagliptin in humans. NIH National Library of Medicine. National Center for Biotechnology Information.PubMed.gov. [Revised in September 2011] [Accessed on 16th October 2024] click here

3. Kalyan Kumar Gangopadhyay and Parminder Singh. Consensus Statement on Dose Modifications of Antidiabetic Agents in Patients with Hepatic Impairment. NIH National Library of Medicine. National Center for Biotechnology Information. PMC PubMed Central. [Revised in March 2017] [Accessed on 16th October 2024] click here

4. Novartis Europharm Limited. Electronic Medicines Compendium (EMC) [Revised in August 2023] [Accessed on 16th October 2024] click here

5. Novartis Pharma GmbH. European Medicines Agency (EMA). [Revised in July 2012] [Accessed on 16th October 2024] click here

User Feedback

 

 

Author Details

Written By Srilekha. R - B.Pharm
Reviewed For Accuracy By Dr. Jaya Prabakaran - MBBS, MD (Diabetology and Family Medicine)
Last updated on 19 Nov 2024 | 04:11 PM(IST)
Lab updated